eng Science and Education Publishing American Journal of Clinical Medicine Research 2328-403X 2014-02-09 2 1 32 35 10.12691/ajcmr-2-1-8 AJCMR2014218 article Mehmet Ali ERKURT 1 Ilhami BERBER drilhamiberber@hotmail.com 1 Irfan KUKU 1 Emin KAYA 1 Ilknur NIZAM 1 Department of Hematology, Faculty of Medicine, Inonu University, Malatya, Turkey Allogeneic hematopoietic stem cell transplant is safe and curative treatment modality for many hematologic diseases. Expanding alternative donor options such as haploidentical hematopoietic stem cell transplantation and umbilical cord blood, taken together with enhanced outcomes of matched unrelated donors, has resulted in a advisable donor for most patients with an hematopoietic stem cell transplantation indication. This review article provides improved patient selection, offers hope for decreasing relapse and improving outcomes for in patients applied allogeneic hematopoietic stem cell transplant. http://pubs.sciepub.com/ajcmr/2/1/8/ajcmr-2-1-8.pdf allogeneicdonor selectionstem cell transplantation